What Are the Strategies to Minimize Immunogenicity?
Several strategies can be employed to minimize immunogenicity:
Surface Engineering: Modifying the surface properties of the catalyst to reduce recognition by the immune system. Biocompatible Coatings: Applying coatings that are known to be biocompatible, such as PEG, to mask the catalyst from the immune system. Controlled Release Systems: Designing catalysts that release their active components in a controlled manner to minimize immune activation. Immunosuppressive Agents: Co-administering immunosuppressive agents to reduce the immune response.
